Anavex Life Sciences (NASDAQ:AVXL) reported quarterly earnings results on February 09, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.06, beating the consensus estimate of $-0.11 by $0.05 per share. Revenue came in at , meeting the estimate of .
Anavex Life Sciences's stock moved following the earnings release. The stock currently trades at $4.15 with a market capitalization of $367.2M.